// Workers AI · dad joke modeWhy did Threonine–tRNA ligase go to therapy? It had an amino acid to work through.
| TARS2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aliases | TARS2, COXPD21, TARSL1, thrRS, threonyl-tRNA synthetase 2, mitochondrial (putative), threonyl-tRNA synthetase 2, mitochondrial | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| External IDs | OMIM: 612805; MGI: 1919057; GeneCards: TARS2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Wikidata | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Threonine–tRNA ligase, mitochondrial, also called threonyl-tRNA synthetase 2, is an enzyme that in humans is encoded by the TARS2 gene.[5][6] Like the related cytosolic threonine–tRNA ligase, TARS1, this enzyme functions to attach the amino acid threonine to its corresponding transfer RNA (tRNAThr).[6] This produces an aminoacyl-tRNA which is needed to incorporate threonine into proteins during RNA-to-protein translation.[7]
Function
[edit]
This enzyme is part of the class-II aminoacyl-tRNA synthetase family.[5] Aminoacyl tRNA synthetases are enzymes that charge tRNA with the amino acids of the appropriate type, which in this case means attaching threonine to tRNAThr.[7] During translation, the produced aminoacyl-tRNAs are used to translate the mRNA code into the corresponding amino acid sequence and protein.[7]
Medical Significance
[edit]Pathogenic mutations in TARS2 are associated with a growth defects, seizures, and early death, called combined oxidative phosphorylation deficiency-21 (COXPD21).[8] This illness appears to follow an autosomal recessive inheritance pattern.[8]
References
[edit]- 1 2 3 GRCh38: Ensembl release 89: ENSG00000143374 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000028107 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- 1 2 "TARS2 threonyl-tRNA synthetase 2, mitochondrial". Entrez Gene. NCBI. Retrieved 2026-09-30.
- 1 2 "Threonine--tRNA ligase, mitochondrial". uniprot.org. UniProt consortium. Retrieved 2026-09-30.
- 1 2 3 Gomez MA, Ibba M (2020-04-17). "Aminoacyl-tRNA synthetases". Rna. doi:10.1261/rna.071720.119. PMC 7373986.
- 1 2 Kniffin CL, Vernon HJ (2025-03-25). "COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21; COXPD21". Online Mendelian Inheritance in Man. Johns Hopkins University. Retrieved 2026-09-30.